Sign-in | Register

NIRI names ARCA biopharma’s Derek Cole as new chair

Comments (0) | 28 Sep 2011 | Rating Rating (-1 to +1): 0.0

| Print by Tim Human

Biotech specialist takes over as NIRI prepares to implement new strategic plan

NIRI has appointed Derek Cole, vice president of IR and corporate communications at ARCA biopharma, as its chair of the board of directors for 2012.

He will succeed Douglas Wilburne, vice president of IR at Textron, who steps down at the end of the year.

Cole joins NIRI, the world ...

Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.

Become a subscriber for unlimited access.